| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 265.20 | 14.3% | 38.5% |
| Total Income | 265.20 | 14.3% | 38.5% |
| Expenditure | 364.19 | 7.6% | 17.9% |
| PBT | -92.59 | 7.3% | 14.1% |
| Net Profit | -92.73 | 7.2% | 13.9% |
| OPM | -37.33% | 8.52pp | 23.95pp |
| NPM | -34.97% | 8.08pp | 21.31pp |
| EPS | -0.74 | 7.5% | 15.9% |
Guardant Health Announces Q3 2025 Financial Results
04 May 2026 · 4 May, 8:34 am
Summary
The press release announces the financial results for the fiscal quarter ended September 30, 2025. Further details are available in Exhibit 99.1.
Informational and educational content only. Not investment advice.